Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another.
Pierre CabantousSylvie DaliphardVictor BobéePublished in: Clinical case reports (2020)
Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.